Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satyajit Das

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 1, 2011
Overcoming multidrug resistance (MDR) in cancer in vitro and in vivo by a quinoline derivativeAvishek Ganguly, Kaushik Banerjee, Paramita Chakraborty, et al.
Nature Chemical Biology|September 1, 2022
Affinity-matured DLL4 ligands as broad-spectrum modulators of Notch signalingDavid Gonzalez-Perez, Satyajit Das, Daniel Antfolk, et al.
Antiviral Therapy|February 4, 2012
Evidence for a shift to anaerobic metabolism in adipose tissue in efavirenz-containing regimens for HIV with different nucleoside backbonesKirsty C McGee, Mohsen Shahmanesh, Meg Boothby, et al.
The Lancet. HIV|January 9, 2017
Effect of immediate initiation of antiretroviral therapy on risk of severe bacterial infections in HIV-positive people with CD4 cell counts of more than 500 cells per μL: secondary outcome results from a randomised controlled trialJemma O'Connor, Michael J Vjecha, Andrew N Phillips, et al.
Cancer Immunology Research|January 20, 2026
Medium-Chain Fatty Acid Receptor GPR84 Modulates Cytotoxic CD8 T cells Antitumor Immunity Through Metabolic ReprogrammingPhaethon Philbrook, Matthew J Dean, Maria Dulfary Sanchez-Pino, et al.
Science Advances|November 15, 2024
H<sub>2</sub>S-Prdx4 axis mitigates Golgi stress to bolster tumor-reactive T cell immunotherapeutic responseNathaniel Oberholtzer, Paramita Chakraborty, Mohamed Faisal Kassir, et al.
Cancer Cell|September 23, 2022
Ablation of the endoplasmic reticulum stress kinase PERK induces paraptosis and type I interferon to promote anti-tumor T cell responsesJessica K Mandula, Shiun Chang, Eslam Mohamed, et al.
Nature Communications|June 2, 2026
Sphingosine kinase-2 inhibition promotes immunogenic differentiation of myeloid-derived suppressor cells through an Acetyl-CoA carboxylase-phosphatidylcholine axisParamita Chakraborty, Shilpak Chatterjee, Mohamed Faisal Kassir, et al.
Immunity|April 18, 2024
Jagged2 targeting in lung cancer activates anti-tumor immunity via Notch-induced functional reprogramming of tumor-associated macrophagesJay K Mandula, Rosa A Sierra-Mondragon, Rachel V Jimenez, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 1, 2011
Overcoming multidrug resistance (MDR) in cancer in vitro and in vivo by a quinoline derivativeAvishek Ganguly, Kaushik Banerjee, Paramita Chakraborty, et al.
Nature Chemical Biology|September 1, 2022
Affinity-matured DLL4 ligands as broad-spectrum modulators of Notch signalingDavid Gonzalez-Perez, Satyajit Das, Daniel Antfolk, et al.
Antiviral Therapy|February 4, 2012
Evidence for a shift to anaerobic metabolism in adipose tissue in efavirenz-containing regimens for HIV with different nucleoside backbonesKirsty C McGee, Mohsen Shahmanesh, Meg Boothby, et al.
The Lancet. HIV|January 9, 2017
Effect of immediate initiation of antiretroviral therapy on risk of severe bacterial infections in HIV-positive people with CD4 cell counts of more than 500 cells per μL: secondary outcome results from a randomised controlled trialJemma O'Connor, Michael J Vjecha, Andrew N Phillips, et al.
Cancer Immunology Research|January 20, 2026
Medium-Chain Fatty Acid Receptor GPR84 Modulates Cytotoxic CD8 T cells Antitumor Immunity Through Metabolic ReprogrammingPhaethon Philbrook, Matthew J Dean, Maria Dulfary Sanchez-Pino, et al.
Science Advances|November 15, 2024
H<sub>2</sub>S-Prdx4 axis mitigates Golgi stress to bolster tumor-reactive T cell immunotherapeutic responseNathaniel Oberholtzer, Paramita Chakraborty, Mohamed Faisal Kassir, et al.
Cancer Cell|September 23, 2022
Ablation of the endoplasmic reticulum stress kinase PERK induces paraptosis and type I interferon to promote anti-tumor T cell responsesJessica K Mandula, Shiun Chang, Eslam Mohamed, et al.
Nature Communications|June 2, 2026
Sphingosine kinase-2 inhibition promotes immunogenic differentiation of myeloid-derived suppressor cells through an Acetyl-CoA carboxylase-phosphatidylcholine axisParamita Chakraborty, Shilpak Chatterjee, Mohamed Faisal Kassir, et al.
Immunity|April 18, 2024
Jagged2 targeting in lung cancer activates anti-tumor immunity via Notch-induced functional reprogramming of tumor-associated macrophagesJay K Mandula, Rosa A Sierra-Mondragon, Rachel V Jimenez, et al.
Pageof 6